Konjenital hipogonadotropik hipogonadizm hastalarında testosteron replasman tedavisinin inflamasyon ve insülin direncine etkisi
Cardio-metabolic risk is increased in hypogonadism. The effect of testosterone replacement treatment (TRT) on the cardiovascular and metabolic outcomes in hypogonadal patients is not clear. We investigated the effect of TRT on the insulin resistance and inflammation in patients with congenital hypog...
Gespeichert in:
| Veröffentlicht in: | Gülhane tıp dergisi 2016-12, Vol.58 (4), p.394 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng ; tur |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 4 |
| container_start_page | 394 |
| container_title | Gülhane tıp dergisi |
| container_volume | 58 |
| creator | Haymana, Cem Sönmez, Alper Aydoğdu, Aydoğan Taşlıpınar, Abdullah Coşkun Meriç Başaran, Yalçın Dinç, Mustafa Demir, Orhan Azal, Ömer Serkan Tapan |
| description | Cardio-metabolic risk is increased in hypogonadism. The effect of testosterone replacement treatment (TRT) on the cardiovascular and metabolic outcomes in hypogonadal patients is not clear. We investigated the effect of TRT on the insulin resistance and inflammation in patients with congenital hypogonadotrophic hypogonadism (CHH). A total of 80 patients with CHH (mean age 21,5±2,13 years) were enrolled. TRT was implemented in injectable and transdermal form. The demographic parameters, Pentraxin-3 (PTX3), high sensitive C reactive protein (hs-CRP) and homeostatic model assessment of insulin resistance (HOMA-IR) levels were measured before and after TRT. After 6,0±2.41 months of TRT, body mass indexes (p |
| doi_str_mv | 10.5455/gulhane.233026 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2440117178</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2440117178</sourcerecordid><originalsourceid>FETCH-proquest_journals_24401171783</originalsourceid><addsrcrecordid>eNqNjbFOwzAURS0EEhF0ZbbEnGI7TtwdgZBY2asHcZvXOs_Bz6kEG5_EzgYfhgck1k5X99wjXSGutFq2tm1vtnMYgPzSNI0y3YmojLZdvVKtORWVLqxW1ulzsWDGZ2Wtc43udCU-HiPtPGGGIAec4jYS9DGnOOH-H-D7KAfgIkH6-aQeZPacI2efIsnkpwA8AhXawwEZCUkibQKMwG_FOPhS-fsrFN5j8vSC5KXP--JeirMNBPaLv7wQ1_d3T7cP9ZTi61xu1rs4JyrT2lirtHbarZrjrF-GDl1W</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2440117178</pqid></control><display><type>article</type><title>Konjenital hipogonadotropik hipogonadizm hastalarında testosteron replasman tedavisinin inflamasyon ve insülin direncine etkisi</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Haymana, Cem ; Sönmez, Alper ; Aydoğdu, Aydoğan ; Taşlıpınar, Abdullah ; Coşkun Meriç ; Başaran, Yalçın ; Dinç, Mustafa ; Demir, Orhan ; Azal, Ömer ; Serkan Tapan</creator><creatorcontrib>Haymana, Cem ; Sönmez, Alper ; Aydoğdu, Aydoğan ; Taşlıpınar, Abdullah ; Coşkun Meriç ; Başaran, Yalçın ; Dinç, Mustafa ; Demir, Orhan ; Azal, Ömer ; Serkan Tapan</creatorcontrib><description>Cardio-metabolic risk is increased in hypogonadism. The effect of testosterone replacement treatment (TRT) on the cardiovascular and metabolic outcomes in hypogonadal patients is not clear. We investigated the effect of TRT on the insulin resistance and inflammation in patients with congenital hypogonadotrophic hypogonadism (CHH). A total of 80 patients with CHH (mean age 21,5±2,13 years) were enrolled. TRT was implemented in injectable and transdermal form. The demographic parameters, Pentraxin-3 (PTX3), high sensitive C reactive protein (hs-CRP) and homeostatic model assessment of insulin resistance (HOMA-IR) levels were measured before and after TRT. After 6,0±2.41 months of TRT, body mass indexes (p<,001), waist circumferences (p=0,001), HOMA-IR (p=0,04) and PTX3 (p=0,02) levels were significantly increased and HDL cholesterol (p<,001) levels were significantly decreased. In the correlation analysis, there was no association between testosterone and PTX3, hsCRP, HOMA-IR levels, but there was only a significant and negative association between PTX3 and triglyceride levels (r=-0,28 p=0,03). The Results of the present study show that TRT has a negative effect on the insulin resistance and inflammation in patients with CHH. Whether this is an early implication of TRT related adverse effects in this very young and treatment naïve population of CHH is not clear. Future prospective studies are required to find out the long-term effects of TRT on cardio-metabolic morbidity and mortality in this specific population.</description><identifier>ISSN: 1302-0471</identifier><identifier>EISSN: 2146-8052</identifier><identifier>DOI: 10.5455/gulhane.233026</identifier><language>eng ; tur</language><publisher>Ankara: Gulhane Medical Journal</publisher><subject>Insulin resistance ; Metabolism</subject><ispartof>Gülhane tıp dergisi, 2016-12, Vol.58 (4), p.394</ispartof><rights>2016. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids></links><search><creatorcontrib>Haymana, Cem</creatorcontrib><creatorcontrib>Sönmez, Alper</creatorcontrib><creatorcontrib>Aydoğdu, Aydoğan</creatorcontrib><creatorcontrib>Taşlıpınar, Abdullah</creatorcontrib><creatorcontrib>Coşkun Meriç</creatorcontrib><creatorcontrib>Başaran, Yalçın</creatorcontrib><creatorcontrib>Dinç, Mustafa</creatorcontrib><creatorcontrib>Demir, Orhan</creatorcontrib><creatorcontrib>Azal, Ömer</creatorcontrib><creatorcontrib>Serkan Tapan</creatorcontrib><title>Konjenital hipogonadotropik hipogonadizm hastalarında testosteron replasman tedavisinin inflamasyon ve insülin direncine etkisi</title><title>Gülhane tıp dergisi</title><description>Cardio-metabolic risk is increased in hypogonadism. The effect of testosterone replacement treatment (TRT) on the cardiovascular and metabolic outcomes in hypogonadal patients is not clear. We investigated the effect of TRT on the insulin resistance and inflammation in patients with congenital hypogonadotrophic hypogonadism (CHH). A total of 80 patients with CHH (mean age 21,5±2,13 years) were enrolled. TRT was implemented in injectable and transdermal form. The demographic parameters, Pentraxin-3 (PTX3), high sensitive C reactive protein (hs-CRP) and homeostatic model assessment of insulin resistance (HOMA-IR) levels were measured before and after TRT. After 6,0±2.41 months of TRT, body mass indexes (p<,001), waist circumferences (p=0,001), HOMA-IR (p=0,04) and PTX3 (p=0,02) levels were significantly increased and HDL cholesterol (p<,001) levels were significantly decreased. In the correlation analysis, there was no association between testosterone and PTX3, hsCRP, HOMA-IR levels, but there was only a significant and negative association between PTX3 and triglyceride levels (r=-0,28 p=0,03). The Results of the present study show that TRT has a negative effect on the insulin resistance and inflammation in patients with CHH. Whether this is an early implication of TRT related adverse effects in this very young and treatment naïve population of CHH is not clear. Future prospective studies are required to find out the long-term effects of TRT on cardio-metabolic morbidity and mortality in this specific population.</description><subject>Insulin resistance</subject><subject>Metabolism</subject><issn>1302-0471</issn><issn>2146-8052</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNqNjbFOwzAURS0EEhF0ZbbEnGI7TtwdgZBY2asHcZvXOs_Bz6kEG5_EzgYfhgck1k5X99wjXSGutFq2tm1vtnMYgPzSNI0y3YmojLZdvVKtORWVLqxW1ulzsWDGZ2Wtc43udCU-HiPtPGGGIAec4jYS9DGnOOH-H-D7KAfgIkH6-aQeZPacI2efIsnkpwA8AhXawwEZCUkibQKMwG_FOPhS-fsrFN5j8vSC5KXP--JeirMNBPaLv7wQ1_d3T7cP9ZTi61xu1rs4JyrT2lirtHbarZrjrF-GDl1W</recordid><startdate>20161201</startdate><enddate>20161201</enddate><creator>Haymana, Cem</creator><creator>Sönmez, Alper</creator><creator>Aydoğdu, Aydoğan</creator><creator>Taşlıpınar, Abdullah</creator><creator>Coşkun Meriç</creator><creator>Başaran, Yalçın</creator><creator>Dinç, Mustafa</creator><creator>Demir, Orhan</creator><creator>Azal, Ömer</creator><creator>Serkan Tapan</creator><general>Gulhane Medical Journal</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20161201</creationdate><title>Konjenital hipogonadotropik hipogonadizm hastalarında testosteron replasman tedavisinin inflamasyon ve insülin direncine etkisi</title><author>Haymana, Cem ; Sönmez, Alper ; Aydoğdu, Aydoğan ; Taşlıpınar, Abdullah ; Coşkun Meriç ; Başaran, Yalçın ; Dinç, Mustafa ; Demir, Orhan ; Azal, Ömer ; Serkan Tapan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_24401171783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; tur</language><creationdate>2016</creationdate><topic>Insulin resistance</topic><topic>Metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haymana, Cem</creatorcontrib><creatorcontrib>Sönmez, Alper</creatorcontrib><creatorcontrib>Aydoğdu, Aydoğan</creatorcontrib><creatorcontrib>Taşlıpınar, Abdullah</creatorcontrib><creatorcontrib>Coşkun Meriç</creatorcontrib><creatorcontrib>Başaran, Yalçın</creatorcontrib><creatorcontrib>Dinç, Mustafa</creatorcontrib><creatorcontrib>Demir, Orhan</creatorcontrib><creatorcontrib>Azal, Ömer</creatorcontrib><creatorcontrib>Serkan Tapan</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Gülhane tıp dergisi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haymana, Cem</au><au>Sönmez, Alper</au><au>Aydoğdu, Aydoğan</au><au>Taşlıpınar, Abdullah</au><au>Coşkun Meriç</au><au>Başaran, Yalçın</au><au>Dinç, Mustafa</au><au>Demir, Orhan</au><au>Azal, Ömer</au><au>Serkan Tapan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Konjenital hipogonadotropik hipogonadizm hastalarında testosteron replasman tedavisinin inflamasyon ve insülin direncine etkisi</atitle><jtitle>Gülhane tıp dergisi</jtitle><date>2016-12-01</date><risdate>2016</risdate><volume>58</volume><issue>4</issue><spage>394</spage><pages>394-</pages><issn>1302-0471</issn><eissn>2146-8052</eissn><abstract>Cardio-metabolic risk is increased in hypogonadism. The effect of testosterone replacement treatment (TRT) on the cardiovascular and metabolic outcomes in hypogonadal patients is not clear. We investigated the effect of TRT on the insulin resistance and inflammation in patients with congenital hypogonadotrophic hypogonadism (CHH). A total of 80 patients with CHH (mean age 21,5±2,13 years) were enrolled. TRT was implemented in injectable and transdermal form. The demographic parameters, Pentraxin-3 (PTX3), high sensitive C reactive protein (hs-CRP) and homeostatic model assessment of insulin resistance (HOMA-IR) levels were measured before and after TRT. After 6,0±2.41 months of TRT, body mass indexes (p<,001), waist circumferences (p=0,001), HOMA-IR (p=0,04) and PTX3 (p=0,02) levels were significantly increased and HDL cholesterol (p<,001) levels were significantly decreased. In the correlation analysis, there was no association between testosterone and PTX3, hsCRP, HOMA-IR levels, but there was only a significant and negative association between PTX3 and triglyceride levels (r=-0,28 p=0,03). The Results of the present study show that TRT has a negative effect on the insulin resistance and inflammation in patients with CHH. Whether this is an early implication of TRT related adverse effects in this very young and treatment naïve population of CHH is not clear. Future prospective studies are required to find out the long-term effects of TRT on cardio-metabolic morbidity and mortality in this specific population.</abstract><cop>Ankara</cop><pub>Gulhane Medical Journal</pub><doi>10.5455/gulhane.233026</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1302-0471 |
| ispartof | Gülhane tıp dergisi, 2016-12, Vol.58 (4), p.394 |
| issn | 1302-0471 2146-8052 |
| language | eng ; tur |
| recordid | cdi_proquest_journals_2440117178 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Insulin resistance Metabolism |
| title | Konjenital hipogonadotropik hipogonadizm hastalarında testosteron replasman tedavisinin inflamasyon ve insülin direncine etkisi |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T13%3A50%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Konjenital%20hipogonadotropik%20hipogonadizm%20hastalar%C4%B1nda%20testosteron%20replasman%20tedavisinin%20inflamasyon%20ve%20ins%C3%BClin%20direncine%20etkisi&rft.jtitle=Gu%CC%88lhane%20t%C4%B1p%20dergisi&rft.au=Haymana,%20Cem&rft.date=2016-12-01&rft.volume=58&rft.issue=4&rft.spage=394&rft.pages=394-&rft.issn=1302-0471&rft.eissn=2146-8052&rft_id=info:doi/10.5455/gulhane.233026&rft_dat=%3Cproquest%3E2440117178%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2440117178&rft_id=info:pmid/&rfr_iscdi=true |